Impact of Epicatechin on the Procoagulant Activities of Microparticles
Microparticles play a role in cardiovascular disease pathology. The flavanol-like epicatechin is increasingly considered due to its cardioprotective effects. The aim of this study was to investigate the impact of epicatechin on microparticle generation, phenotype and procoagulant properties. Plasma...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/12/10/2935 |
id |
doaj-ef279c100b4048c99610f3766b4e54f1 |
---|---|
record_format |
Article |
spelling |
doaj-ef279c100b4048c99610f3766b4e54f12020-11-25T03:28:25ZengMDPI AGNutrients2072-66432020-09-01122935293510.3390/nu12102935Impact of Epicatechin on the Procoagulant Activities of MicroparticlesThomas Sinegre0Dragan Milenkovic1Céline Bourgne2Dorian Teissandier3Yosra Nasri4Louis-Thomas Dannus5Christine Morand6Aurélien Lebreton7UNH Unité de Nutrition Humaine, Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement, Université Clermont Auvergne, 63000 Clermont-Ferrand, FranceUNH Unité de Nutrition Humaine, Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement, Université Clermont Auvergne, 63000 Clermont-Ferrand, FranceCHU Clermont-Ferrand, Service d’Hématologie Biologique, 63000 Clermont-Ferrand, FranceUNH Unité de Nutrition Humaine, Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement, Université Clermont Auvergne, 63000 Clermont-Ferrand, FranceCHU Clermont-Ferrand, Service d’Hématologie Biologique, 63000 Clermont-Ferrand, FranceCHU Clermont-Ferrand, Service d’Hématologie Biologique, 63000 Clermont-Ferrand, FranceUNH Unité de Nutrition Humaine, Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement, Université Clermont Auvergne, 63000 Clermont-Ferrand, FranceUNH Unité de Nutrition Humaine, Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement, Université Clermont Auvergne, 63000 Clermont-Ferrand, FranceMicroparticles play a role in cardiovascular disease pathology. The flavanol-like epicatechin is increasingly considered due to its cardioprotective effects. The aim of this study was to investigate the impact of epicatechin on microparticle generation, phenotype and procoagulant properties. Plasma samples from 15 healthy subjects were incubated with increasing concentrations of epicatechin (1 to 100 μM). Then, the expression of glycoprotein IIb, phosphatidylserine (PS), glycoprotein Ib (GPIb) and P-selectin was assessed by flow cytometry analysis after (or not) platelet stimulation. Microparticle procoagulant activity was determined using Zymuphen<sup>TM</sup> MP and Zymuphen<sup>TM</sup> MP-TF for phospholipid and tissue factor content, and with thrombin generation (TG) assays for procoagulant function. Platelet microparticles that express GPIb (/µL) decreased from 20,743 ± 24,985 (vehicle) to 14,939 ± 14,333 (<i>p</i> = 0.6), 21,366 ± 16,949 (<i>p</i> = 0.9) and 15,425 ± 9953 (<i>p</i> < 0.05) in samples incubated with 1, 10 and 100 µM epicatechin, respectively. Microparticle concentration (nM PS) decreased from 5.6 ± 2.0 (vehicle) to 5.1 ± 2.2 (<i>p</i> = 0.5), 4.5 ± 1.5 (<i>p</i> < 0.05) and 4.7 ± 2.0 (<i>p</i> < 0.05) in samples incubated with 1, 10 and 100µM epicatechin, respectively. Epicatechin had no impact on tissue factor-positive microparticle concentration. Epicatechin decreased TG (endogenous thrombin potential, nM.min) from 586 ± 302 to 509 ± 226 (<i>p</i> = 0.3), 512 ± 270 (<i>p</i> = 0.3) and 445 ± 283 (<i>p</i> < 0.05). These findings indicate that epicatechin affects microparticle release, phenotype and procoagulant properties.https://www.mdpi.com/2072-6643/12/10/2935cardiovascular diseasecoagulationepicatechinhemostasismicroparticles |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Thomas Sinegre Dragan Milenkovic Céline Bourgne Dorian Teissandier Yosra Nasri Louis-Thomas Dannus Christine Morand Aurélien Lebreton |
spellingShingle |
Thomas Sinegre Dragan Milenkovic Céline Bourgne Dorian Teissandier Yosra Nasri Louis-Thomas Dannus Christine Morand Aurélien Lebreton Impact of Epicatechin on the Procoagulant Activities of Microparticles Nutrients cardiovascular disease coagulation epicatechin hemostasis microparticles |
author_facet |
Thomas Sinegre Dragan Milenkovic Céline Bourgne Dorian Teissandier Yosra Nasri Louis-Thomas Dannus Christine Morand Aurélien Lebreton |
author_sort |
Thomas Sinegre |
title |
Impact of Epicatechin on the Procoagulant Activities of Microparticles |
title_short |
Impact of Epicatechin on the Procoagulant Activities of Microparticles |
title_full |
Impact of Epicatechin on the Procoagulant Activities of Microparticles |
title_fullStr |
Impact of Epicatechin on the Procoagulant Activities of Microparticles |
title_full_unstemmed |
Impact of Epicatechin on the Procoagulant Activities of Microparticles |
title_sort |
impact of epicatechin on the procoagulant activities of microparticles |
publisher |
MDPI AG |
series |
Nutrients |
issn |
2072-6643 |
publishDate |
2020-09-01 |
description |
Microparticles play a role in cardiovascular disease pathology. The flavanol-like epicatechin is increasingly considered due to its cardioprotective effects. The aim of this study was to investigate the impact of epicatechin on microparticle generation, phenotype and procoagulant properties. Plasma samples from 15 healthy subjects were incubated with increasing concentrations of epicatechin (1 to 100 μM). Then, the expression of glycoprotein IIb, phosphatidylserine (PS), glycoprotein Ib (GPIb) and P-selectin was assessed by flow cytometry analysis after (or not) platelet stimulation. Microparticle procoagulant activity was determined using Zymuphen<sup>TM</sup> MP and Zymuphen<sup>TM</sup> MP-TF for phospholipid and tissue factor content, and with thrombin generation (TG) assays for procoagulant function. Platelet microparticles that express GPIb (/µL) decreased from 20,743 ± 24,985 (vehicle) to 14,939 ± 14,333 (<i>p</i> = 0.6), 21,366 ± 16,949 (<i>p</i> = 0.9) and 15,425 ± 9953 (<i>p</i> < 0.05) in samples incubated with 1, 10 and 100 µM epicatechin, respectively. Microparticle concentration (nM PS) decreased from 5.6 ± 2.0 (vehicle) to 5.1 ± 2.2 (<i>p</i> = 0.5), 4.5 ± 1.5 (<i>p</i> < 0.05) and 4.7 ± 2.0 (<i>p</i> < 0.05) in samples incubated with 1, 10 and 100µM epicatechin, respectively. Epicatechin had no impact on tissue factor-positive microparticle concentration. Epicatechin decreased TG (endogenous thrombin potential, nM.min) from 586 ± 302 to 509 ± 226 (<i>p</i> = 0.3), 512 ± 270 (<i>p</i> = 0.3) and 445 ± 283 (<i>p</i> < 0.05). These findings indicate that epicatechin affects microparticle release, phenotype and procoagulant properties. |
topic |
cardiovascular disease coagulation epicatechin hemostasis microparticles |
url |
https://www.mdpi.com/2072-6643/12/10/2935 |
work_keys_str_mv |
AT thomassinegre impactofepicatechinontheprocoagulantactivitiesofmicroparticles AT draganmilenkovic impactofepicatechinontheprocoagulantactivitiesofmicroparticles AT celinebourgne impactofepicatechinontheprocoagulantactivitiesofmicroparticles AT dorianteissandier impactofepicatechinontheprocoagulantactivitiesofmicroparticles AT yosranasri impactofepicatechinontheprocoagulantactivitiesofmicroparticles AT louisthomasdannus impactofepicatechinontheprocoagulantactivitiesofmicroparticles AT christinemorand impactofepicatechinontheprocoagulantactivitiesofmicroparticles AT aurelienlebreton impactofepicatechinontheprocoagulantactivitiesofmicroparticles |
_version_ |
1724584355057106944 |